Fresenius Medical Care AG & Co. KGaA (FMS)
Automate Your Wheel Strategy on FMS
With Tiblio's Option Bot, you can configure your own wheel strategy including FMS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol FMS
- Rev/Share 66.435
- Book/Share 52.8422
- PB 0.9074
- Debt/Equity 0.7529
- CurrentRatio 1.461
- ROIC 0.0365
- MktCap 13041162227.891
- FreeCF/Share 6.7587
- PFCF 6.5762
- PE 21.0967
- Debt/Assets 0.3306
- DivYield 0.0311
- ROE 0.0438
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
4 Top-Ranked High Earnings Yield Value Stocks to Buy Right Away
Published: April 15, 2025 by: Zacks Investment Research
Sentiment: Positive
Unlock your portfolio value with value stocks like Alibaba, Fresenius Medical, Helix Energy and Heritage Insurance. All these stocks boast high earnings yield.
Read More
Here's Why Fresenius (FMS) is a Strong Momentum Stock
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Negative
In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
Read More
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Negative
FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.
Read More
4 Stocks Trading Near 52-Week High With More Upside Potential
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.
Read More
4 Low-Beta Healthcare Stocks to Beat Trump's Tariff Blues
Published: April 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
Healthcare stocks like GLID, COR, FMS and LMAT are a safe bet during times of market volatility.
Read More
5 Relative Price Strength Stocks to Navigate Today's Market
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
IHS, ANIP, MD, FMS and TREE are five stocks with explosive relative price strength.
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: April 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
Published: March 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.
Read More
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.
Read More
5 Low Price-to-Book Stocks to Include in Your Portfolio for Gains
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The P/B ratio helps to identify low-priced stocks with high growth prospects. JD, CIO, FMS, ITRI and ENS are some such stocks.
Read More
4 Value Picks That Could Weather Tariff Volatility and Slowing Growth
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. FMS, ENS, GM & ITRI boast a low P/CF ratio.
Read More
4 Top PEG Stocks Based on GARP Approach to Smart Investing
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Neutral
Here are four discounted PEG stocks, JAZZ, FMS, DAN and ITRI, which qualify our screening criteria.
Read More
Is Fresenius Medical Care AG & Co. (FMS) Stock Undervalued Right Now?
Published: March 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
3 Stocks Trading Near 52-Week High With Room to Rise Further
Published: March 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors target stocks that have been on a bullish run lately. Stocks like FMS, DTEGY and THG are seeing price strength and the momentum is likely to continue.
Read More
Best Momentum Stock to Buy for March 18th
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
ASLE, FMS and TEF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 18, 2025.
Read More
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term
Published: March 18, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Fresenius (FMS) is a Strong Value Stock
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Read More
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Published: March 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Positive
FMS, MASI and VCYT from the Zacks Medical Instruments industry are worth buying based on genAI adoption, strategic developments and strong fundamentals. Yet, geopolitical complications and wage and supply issues mar the prospects.
Read More
Fresenius Medical Q4 Earnings Beat Estimates, Revenues Up Y/Y
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
FMS' fourth-quarter results showcase a strong segmental performance along with providing full year 2025 outlook for revenue growth and operating income.
Read More
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025
Published: February 25, 2025 by: PRNewsWire
Sentiment: Neutral
Organic revenue growth1 of 4% driven by Care Enablement and Care Delivery Underlying U.S. same market treatment growth further accelerated in Q4 and turned positive for the full year Accumulated savings of the FME25 program already reached EUR 567 million and 2025 target raised to EUR 750 million With 18% operating income2 growth top end of the 2024 outlook range reached Reported operating income grew by 2%, reported net income3 by +8% Net financial leverage ratio reduced from 3.2x to 2.9x and dividend is planned to be raised by 21% High teens to high twenties percent earnings growth in 2025, …
Read More
Fresenius Medical Care slightly beats market estimates in fourth quarter
Published: February 25, 2025 by: Reuters
Sentiment: Positive
Fresenius Medical Care , the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments.
Read More
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
Published: February 24, 2025 by: PRNewsWire
Sentiment: Neutral
Quest to provide comprehensive dialysis-related laboratory and water testing services to Fresenius Medical Care owned and affiliated clinics in the United States BAD HOMBURG, Germany and SECAUCUS, N.J. , Feb. 24, 2025 /PRNewswire/ -- Fresenius Medical Care (XETRA: FME; NYSE: FMS), the world's leading provider of products and services for individuals with renal disease, and Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that, under terms of a definitive acquisition agreement, Quest will acquire select assets of FME's wholly owned Spectra Laboratories, a leading provider of renal-specific laboratory testing services in the U.S. In addition, …
Read More
About Fresenius Medical Care AG & Co. KGaA (FMS)
- IPO Date 1996-09-17
- Website https://www.freseniusmedicalcare.com
- Industry Medical - Care Facilities
- CEO Helen Giza
- Employees 112035